Temasek to buy 20 pct in Godrej Industries agri unit

MUMBAI Mon Dec 17, 2012 6:00pm IST

Related Topics

Stocks

   

MUMBAI (Reuters) - Godrej Industries (GODI.NS) said on Monday Singapore's Temasek TEM.UL will buy 20 percent stake in the former's agriculture business unit for 5.72 billion rupees to fund the unit's expansion plans.

This is Temasek's second investment in India's Godrej group this year after it invested $136 million for a 4.9 percent stake in Godrej Consumer Products Ltd (GOCP.NS) early this year.

The agriculture business unit Godrej Agrovet Ltd generated 24.6 billion rupees in sales during the financial year ended March 2012. The company has interests in animal feed, oil palm, agri-inputs and poultry, Godrej Industries said in a statement.

HSBC was the sole adviser to the transaction.

Private equity investments in India have fallen 17 percent this year to about $3.3 billion, according to Thomson Reuters data as lack of returns hampered investment sentiment.

Temasek, which manages about $198 billion globally, has investments in India's top mobile operator Bharti Airtel (BRTI.NS) and No.2 Indian lender ICICI Bank (ICBK.NS).

(Reporting by Indulal PM; Editing by G.Ram Mohan)

FILED UNDER:

"India's Daughter"

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage